- Home
- CHRS vs ALTO Comparison
CHRS vs ALTO Comparison
Compare CHRS & ALTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- ALTO
- Stock Information
- Founded
- CHRS 2010
- ALTO 2003
- Country
- CHRS United States
- ALTO United States
- Employees
- CHRS N/A
- ALTO N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- ALTO Major Chemicals
- Sector
- CHRS Health Care
- ALTO Industrials
- Exchange
- CHRS Nasdaq
- ALTO Nasdaq
- Market Cap
- CHRS 84.2M
- ALTO 90.3M
- IPO Year
- CHRS 2014
- ALTO N/A
- Fundamental
- Price
- CHRS $0.76
- ALTO $1.16
- Analyst Decision
- CHRS Buy
- ALTO Strong Buy
- Analyst Count
- CHRS 3
- ALTO 1
- Target Price
- CHRS $4.68
- ALTO $5.50
- AVG Volume (30 Days)
- CHRS 1.3M
- ALTO 327.2K
- Earning Date
- CHRS 08-07-2025
- ALTO 08-05-2025
- Dividend Yield
- CHRS N/A
- ALTO N/A
- EPS Growth
- CHRS N/A
- ALTO N/A
- EPS
- CHRS N/A
- ALTO N/A
- Revenue
- CHRS $272,251,000.00
- ALTO $951,169,000.00
- Revenue This Year
- CHRS N/A
- ALTO N/A
- Revenue Next Year
- CHRS $106.56
- ALTO $7.68
- P/E Ratio
- CHRS N/A
- ALTO N/A
- Revenue Growth
- CHRS 19.87
- ALTO N/A
- 52 Week Low
- CHRS $0.66
- ALTO $0.76
- 52 Week High
- CHRS $2.43
- ALTO $2.05
- Technical
- Relative Strength Index (RSI)
- CHRS 46.35
- ALTO 60.57
- Support Level
- CHRS $0.72
- ALTO $1.11
- Resistance Level
- CHRS $0.77
- ALTO $1.20
- Average True Range (ATR)
- CHRS 0.04
- ALTO 0.09
- MACD
- CHRS 0.00
- ALTO -0.00
- Stochastic Oscillator
- CHRS 38.69
- ALTO 54.17
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include major food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, Western production, and Others.